| 6.5 |
26.0 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 5.3 |
15.8 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 4.6 |
13.9 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 4.6 |
13.9 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 4.5 |
13.4 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 4.2 |
12.7 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 4.1 |
12.4 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 4.0 |
12.1 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 3.6 |
7.2 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 3.6 |
10.7 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 3.4 |
23.9 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 3.4 |
17.0 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 3.3 |
26.1 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 3.3 |
9.8 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 3.1 |
3.1 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 3.1 |
9.2 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 3.0 |
9.1 |
GO:0031052 |
programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
| 3.0 |
9.0 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 2.9 |
8.6 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 2.8 |
8.4 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 2.8 |
8.4 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 2.7 |
2.7 |
GO:1901977 |
negative regulation of cell cycle checkpoint(GO:1901977) |
| 2.7 |
10.6 |
GO:0006203 |
dGTP catabolic process(GO:0006203) dATP catabolic process(GO:0046061) |
| 2.6 |
28.9 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 2.6 |
7.8 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 2.6 |
10.4 |
GO:0071033 |
nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 2.6 |
15.4 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 2.6 |
15.3 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 2.4 |
9.8 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 2.4 |
7.1 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 2.3 |
4.6 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 2.3 |
18.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 2.2 |
30.6 |
GO:0009191 |
ribonucleoside diphosphate catabolic process(GO:0009191) |
| 2.2 |
8.6 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 2.1 |
8.3 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 2.0 |
2.0 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 2.0 |
39.8 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 2.0 |
7.8 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 1.9 |
72.0 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 1.9 |
13.4 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 1.9 |
7.4 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 1.8 |
7.1 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 1.7 |
10.5 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 1.7 |
10.4 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 1.7 |
8.6 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 1.7 |
6.7 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 1.7 |
6.7 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 1.7 |
6.6 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 1.7 |
3.3 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 1.6 |
6.6 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 1.6 |
13.2 |
GO:0030578 |
PML body organization(GO:0030578) |
| 1.6 |
20.8 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 1.6 |
6.4 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 1.6 |
50.6 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 1.6 |
1.6 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 1.5 |
6.2 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 1.5 |
4.6 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 1.5 |
4.6 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 1.5 |
21.3 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 1.5 |
4.6 |
GO:0045472 |
response to ether(GO:0045472) |
| 1.5 |
10.5 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 1.5 |
7.5 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 1.5 |
7.5 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) |
| 1.5 |
7.5 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 1.5 |
7.4 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 1.5 |
39.3 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 1.4 |
4.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 1.4 |
1.4 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 1.4 |
7.1 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 1.4 |
24.5 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 1.4 |
1.4 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 1.3 |
6.7 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 1.3 |
5.3 |
GO:1904430 |
negative regulation of t-circle formation(GO:1904430) |
| 1.3 |
5.3 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 1.3 |
5.3 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 1.3 |
7.9 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.3 |
22.0 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 1.3 |
3.8 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 1.3 |
8.8 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 1.2 |
46.1 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 1.2 |
5.0 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 1.2 |
6.1 |
GO:0060051 |
negative regulation of protein glycosylation(GO:0060051) |
| 1.2 |
3.6 |
GO:0009169 |
purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) guanosine-containing compound catabolic process(GO:1901069) |
| 1.2 |
4.7 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 1.2 |
3.5 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 1.2 |
3.5 |
GO:0010248 |
B cell negative selection(GO:0002352) response to mycotoxin(GO:0010046) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 1.2 |
3.5 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 1.2 |
7.0 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 1.2 |
12.8 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 1.2 |
4.6 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 1.1 |
3.4 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 1.1 |
5.7 |
GO:0060744 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 1.1 |
17.1 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 1.1 |
5.6 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 1.1 |
12.3 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 1.1 |
20.1 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 1.1 |
4.5 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 1.1 |
3.3 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 1.1 |
21.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 1.1 |
12.1 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 1.1 |
5.4 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 1.1 |
4.3 |
GO:0006220 |
pyrimidine nucleotide metabolic process(GO:0006220) |
| 1.1 |
5.4 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 1.1 |
3.2 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 1.1 |
19.2 |
GO:0061615 |
glycolytic process through fructose-6-phosphate(GO:0061615) |
| 1.1 |
6.4 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 1.1 |
6.4 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 1.1 |
13.9 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 1.1 |
3.2 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 1.0 |
10.4 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 1.0 |
7.2 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 1.0 |
1.0 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 1.0 |
19.6 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 1.0 |
1.0 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 1.0 |
3.1 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.0 |
2.0 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 1.0 |
7.1 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 1.0 |
4.9 |
GO:0018202 |
peptidyl-histidine modification(GO:0018202) |
| 1.0 |
3.9 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 1.0 |
3.9 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 1.0 |
2.9 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 1.0 |
1.9 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 1.0 |
13.4 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 1.0 |
2.9 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 1.0 |
4.8 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.9 |
3.8 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.9 |
3.8 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.9 |
1.9 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.9 |
2.8 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.9 |
2.8 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.9 |
12.0 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.9 |
9.2 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.9 |
0.9 |
GO:0009136 |
ADP biosynthetic process(GO:0006172) nucleoside diphosphate biosynthetic process(GO:0009133) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) dATP metabolic process(GO:0046060) |
| 0.9 |
9.1 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.9 |
0.9 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.9 |
2.7 |
GO:0001839 |
neural plate morphogenesis(GO:0001839) |
| 0.9 |
8.0 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.9 |
2.7 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.9 |
7.9 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.9 |
2.6 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.9 |
1.7 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.9 |
17.4 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.9 |
3.5 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.9 |
1.7 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.9 |
0.9 |
GO:2000642 |
negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.9 |
11.1 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.9 |
2.6 |
GO:0033024 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.8 |
28.0 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.8 |
14.4 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.8 |
3.4 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.8 |
0.8 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.8 |
1.7 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.8 |
2.5 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.8 |
2.5 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.8 |
4.2 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.8 |
5.0 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.8 |
4.9 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.8 |
16.2 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.8 |
4.0 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.8 |
3.2 |
GO:0061626 |
pharyngeal arch artery morphogenesis(GO:0061626) |
| 0.8 |
3.2 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.8 |
3.2 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.8 |
0.8 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.8 |
5.5 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.8 |
5.4 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.8 |
2.3 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.8 |
1.5 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
| 0.8 |
6.1 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.8 |
2.3 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.8 |
45.3 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.8 |
3.0 |
GO:0033002 |
muscle cell proliferation(GO:0033002) smooth muscle cell proliferation(GO:0048659) |
| 0.8 |
3.8 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.8 |
1.5 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.8 |
0.8 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.8 |
3.8 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.7 |
2.2 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.7 |
2.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.7 |
2.9 |
GO:0070827 |
chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
| 0.7 |
2.2 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.7 |
5.8 |
GO:0045023 |
G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) negative regulation of G0 to G1 transition(GO:0070317) |
| 0.7 |
1.5 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.7 |
8.7 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.7 |
4.3 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.7 |
0.7 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 0.7 |
4.3 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.7 |
32.1 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.7 |
5.0 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.7 |
2.1 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.7 |
3.6 |
GO:0090224 |
regulation of spindle organization(GO:0090224) |
| 0.7 |
0.7 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.7 |
1.4 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.7 |
1.4 |
GO:0060558 |
regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
| 0.7 |
0.7 |
GO:0036499 |
PERK-mediated unfolded protein response(GO:0036499) |
| 0.7 |
2.1 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.7 |
2.8 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.7 |
0.7 |
GO:0046070 |
dGTP metabolic process(GO:0046070) |
| 0.7 |
2.7 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.7 |
2.7 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.7 |
16.3 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.7 |
1.3 |
GO:0009838 |
abscission(GO:0009838) |
| 0.7 |
1.3 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.7 |
4.7 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.7 |
4.0 |
GO:1901978 |
positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.7 |
4.6 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.7 |
2.6 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.7 |
3.9 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.7 |
3.3 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.6 |
1.9 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.6 |
12.3 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.6 |
16.1 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.6 |
23.9 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.6 |
4.5 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.6 |
1.9 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.6 |
63.0 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.6 |
5.1 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.6 |
1.9 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.6 |
10.5 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.6 |
0.6 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.6 |
127.5 |
GO:0000398 |
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 0.6 |
1.8 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.6 |
1.2 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.6 |
1.8 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.6 |
4.2 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.6 |
2.4 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.6 |
3.6 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.6 |
6.5 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.6 |
2.3 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.6 |
3.5 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.6 |
2.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.6 |
5.2 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.6 |
0.6 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.6 |
1.7 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.6 |
2.9 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.6 |
3.4 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.6 |
5.7 |
GO:0051299 |
centrosome separation(GO:0051299) |
| 0.6 |
1.7 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.6 |
0.6 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.6 |
1.1 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.6 |
1.7 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.6 |
1.7 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.6 |
1.7 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.6 |
5.0 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.6 |
7.8 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.6 |
3.3 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.6 |
52.9 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.6 |
7.8 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.6 |
2.8 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.5 |
1.1 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.5 |
3.8 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.5 |
2.2 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.5 |
2.2 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.5 |
2.2 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.5 |
2.1 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.5 |
5.3 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.5 |
3.6 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.5 |
1.0 |
GO:0097345 |
mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.5 |
5.5 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.5 |
10.0 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.5 |
1.0 |
GO:0042505 |
tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
| 0.5 |
1.0 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.5 |
1.5 |
GO:0072070 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) chemoattraction of axon(GO:0061642) loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 0.5 |
1.4 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.5 |
2.4 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.5 |
3.3 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.5 |
2.4 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.5 |
1.9 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.5 |
1.4 |
GO:0009130 |
pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
| 0.5 |
0.5 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.5 |
7.9 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.5 |
1.4 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.5 |
3.7 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.5 |
1.4 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.4 |
1.3 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.4 |
6.6 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.4 |
2.7 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.4 |
5.2 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.4 |
3.0 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.4 |
3.9 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.4 |
4.7 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.4 |
1.7 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.4 |
3.8 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.4 |
0.9 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.4 |
10.1 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.4 |
0.8 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.4 |
0.8 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.4 |
1.2 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.4 |
2.9 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.4 |
2.5 |
GO:0007320 |
insemination(GO:0007320) |
| 0.4 |
2.4 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.4 |
1.2 |
GO:0006106 |
fumarate metabolic process(GO:0006106) aspartate catabolic process(GO:0006533) alditol biosynthetic process(GO:0019401) |
| 0.4 |
2.0 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.4 |
2.0 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.4 |
7.6 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.4 |
3.2 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.4 |
2.4 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.4 |
0.4 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.4 |
1.2 |
GO:0010986 |
complement receptor mediated signaling pathway(GO:0002430) GPI anchor release(GO:0006507) positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.4 |
7.1 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.4 |
10.6 |
GO:0043039 |
tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
| 0.4 |
2.0 |
GO:0045910 |
negative regulation of DNA recombination(GO:0045910) |
| 0.4 |
1.2 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) phosphate ion transmembrane transport(GO:0035435) |
| 0.4 |
4.3 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.4 |
0.8 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.4 |
1.1 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.4 |
3.0 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.4 |
1.5 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.4 |
1.9 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.4 |
1.5 |
GO:0071479 |
cellular response to ionizing radiation(GO:0071479) |
| 0.4 |
4.1 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.4 |
0.4 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.4 |
0.4 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.4 |
1.5 |
GO:0052803 |
imidazole-containing compound metabolic process(GO:0052803) |
| 0.4 |
1.4 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.4 |
2.2 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.4 |
5.0 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.4 |
0.4 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.4 |
0.7 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 |
0.3 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.3 |
1.0 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.3 |
23.3 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.3 |
1.4 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.3 |
1.7 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.3 |
1.3 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.3 |
1.0 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.3 |
0.7 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.3 |
1.0 |
GO:0045404 |
positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.3 |
1.0 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.3 |
2.9 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.3 |
1.3 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.3 |
0.6 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.3 |
0.9 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.3 |
4.4 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.3 |
0.9 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.3 |
1.9 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.3 |
0.6 |
GO:0001824 |
blastocyst development(GO:0001824) |
| 0.3 |
0.9 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.3 |
8.2 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.3 |
2.4 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.3 |
0.6 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 0.3 |
3.6 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.3 |
2.4 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.3 |
2.1 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.3 |
3.5 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.3 |
1.2 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.3 |
2.3 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.3 |
0.3 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) protein insertion into mitochondrial membrane(GO:0051204) |
| 0.3 |
0.9 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) |
| 0.3 |
0.9 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.3 |
4.3 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.3 |
1.2 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.3 |
1.1 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.3 |
1.1 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.3 |
20.7 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.3 |
0.9 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.3 |
4.2 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.3 |
0.8 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.3 |
0.6 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.3 |
3.0 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.3 |
0.6 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.3 |
0.8 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 |
3.0 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.3 |
2.7 |
GO:0006085 |
acetyl-CoA biosynthetic process(GO:0006085) |
| 0.3 |
1.4 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.3 |
0.5 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.3 |
1.4 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.3 |
0.5 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.3 |
0.5 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.3 |
0.5 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.3 |
1.3 |
GO:0051307 |
meiotic chromosome separation(GO:0051307) |
| 0.3 |
3.5 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.3 |
1.1 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.3 |
2.4 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.3 |
0.8 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.3 |
1.0 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.3 |
0.8 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.3 |
7.3 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.3 |
1.0 |
GO:0046618 |
drug export(GO:0046618) |
| 0.3 |
3.6 |
GO:0044819 |
mitotic G1/S transition checkpoint(GO:0044819) |
| 0.3 |
0.5 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.3 |
0.8 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.3 |
2.0 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.3 |
1.3 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.3 |
1.0 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.3 |
0.8 |
GO:0010717 |
regulation of epithelial to mesenchymal transition(GO:0010717) |
| 0.3 |
0.8 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.3 |
3.3 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.3 |
1.5 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.2 |
15.0 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.2 |
1.2 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.2 |
3.0 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.2 |
1.5 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.2 |
1.2 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.2 |
0.5 |
GO:0003100 |
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) regulation of systemic arterial blood pressure by endothelin(GO:0003100) negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.2 |
1.2 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.2 |
5.5 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.2 |
1.4 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.2 |
1.2 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.2 |
0.7 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.2 |
4.3 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.2 |
0.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 |
5.4 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.2 |
0.5 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 |
0.2 |
GO:0001803 |
type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 0.2 |
0.9 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.2 |
5.1 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.2 |
5.8 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.2 |
1.8 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.2 |
0.9 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.2 |
1.4 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.2 |
0.5 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.2 |
6.8 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.2 |
0.5 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.2 |
1.1 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.2 |
3.9 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.2 |
0.9 |
GO:1904995 |
negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.2 |
1.4 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.2 |
1.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.2 |
0.7 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.2 |
1.6 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.2 |
1.1 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.2 |
0.7 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.2 |
2.2 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.2 |
1.3 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.2 |
2.0 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.2 |
2.8 |
GO:0045589 |
regulation of regulatory T cell differentiation(GO:0045589) |
| 0.2 |
0.7 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.2 |
0.6 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.2 |
0.9 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.2 |
0.4 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.2 |
1.1 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.2 |
0.4 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.2 |
1.9 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.2 |
1.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
2.3 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.2 |
0.4 |
GO:0021508 |
floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
| 0.2 |
2.9 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.2 |
0.4 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.2 |
0.4 |
GO:2000370 |
positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.2 |
8.0 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.2 |
5.9 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.2 |
2.5 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.2 |
2.7 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.2 |
3.5 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.2 |
1.8 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.2 |
0.4 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.2 |
0.6 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.2 |
2.6 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.2 |
8.7 |
GO:0035306 |
positive regulation of dephosphorylation(GO:0035306) |
| 0.2 |
0.6 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.2 |
3.0 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.2 |
1.2 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.2 |
0.2 |
GO:0090085 |
regulation of protein deubiquitination(GO:0090085) |
| 0.2 |
1.0 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.2 |
0.6 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.2 |
0.4 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.2 |
1.9 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.2 |
0.4 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.2 |
2.5 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 |
0.8 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.2 |
1.7 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.2 |
2.7 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.2 |
2.3 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 0.2 |
1.1 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.2 |
0.8 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 |
3.4 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.2 |
4.3 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.2 |
1.3 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.2 |
0.7 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.2 |
0.9 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 |
1.3 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.2 |
4.4 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.2 |
1.8 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.2 |
2.7 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.2 |
0.4 |
GO:0090042 |
tubulin deacetylation(GO:0090042) |
| 0.2 |
10.9 |
GO:0035308 |
negative regulation of protein dephosphorylation(GO:0035308) |
| 0.2 |
0.4 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 |
1.8 |
GO:0098534 |
centriole replication(GO:0007099) centriole assembly(GO:0098534) |
| 0.2 |
0.5 |
GO:0006901 |
vesicle coating(GO:0006901) |
| 0.2 |
0.9 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 |
1.2 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.2 |
0.5 |
GO:0035357 |
peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.2 |
1.4 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 |
0.2 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 |
0.5 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.2 |
0.5 |
GO:0038089 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) protein kinase D signaling(GO:0089700) |
| 0.2 |
1.0 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 |
1.4 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.2 |
1.2 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 |
2.0 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.2 |
0.3 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.2 |
6.0 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.2 |
0.7 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.2 |
0.7 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.2 |
0.7 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.2 |
9.1 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.2 |
1.1 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.2 |
1.9 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.2 |
0.3 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.2 |
0.6 |
GO:0019348 |
polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
| 0.2 |
0.5 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 |
0.5 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.2 |
0.9 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.2 |
1.4 |
GO:0035066 |
positive regulation of histone acetylation(GO:0035066) |
| 0.2 |
2.3 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.2 |
2.3 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 |
0.6 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.2 |
0.9 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 |
7.0 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.2 |
2.1 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.2 |
0.6 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.2 |
2.3 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.2 |
0.6 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.2 |
0.6 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 |
2.7 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.6 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
1.8 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.1 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 |
1.2 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
1.0 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
2.5 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 |
0.6 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.1 |
0.6 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
6.6 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.1 |
3.6 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.1 |
0.8 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
0.3 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.1 |
2.0 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 |
0.7 |
GO:0042891 |
antibiotic transport(GO:0042891) |
| 0.1 |
0.4 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 |
3.6 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
2.4 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
1.1 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
1.5 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
1.0 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.1 |
0.6 |
GO:0043628 |
ncRNA 3'-end processing(GO:0043628) |
| 0.1 |
1.8 |
GO:0006278 |
RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
| 0.1 |
0.8 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
0.8 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.1 |
0.3 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.1 |
0.7 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
8.3 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.1 |
1.3 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.1 |
0.4 |
GO:0032392 |
DNA geometric change(GO:0032392) |
| 0.1 |
0.5 |
GO:0035729 |
response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.1 |
1.2 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.1 |
0.9 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
0.4 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.1 |
0.9 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
2.1 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.1 |
2.5 |
GO:0061028 |
establishment of endothelial barrier(GO:0061028) |
| 0.1 |
0.9 |
GO:0045649 |
regulation of macrophage differentiation(GO:0045649) |
| 0.1 |
0.8 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
1.4 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.1 |
29.5 |
GO:0006412 |
translation(GO:0006412) |
| 0.1 |
1.0 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
2.0 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
1.1 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.9 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.2 |
GO:0021649 |
blastoderm segmentation(GO:0007350) vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) cranial ganglion development(GO:0061550) trigeminal ganglion development(GO:0061551) ganglion morphogenesis(GO:0061552) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) facioacoustic ganglion development(GO:1903375) dorsal root ganglion morphogenesis(GO:1904835) dorsal root ganglion development(GO:1990791) |
| 0.1 |
0.4 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 |
3.4 |
GO:0014706 |
striated muscle tissue development(GO:0014706) |
| 0.1 |
1.1 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.1 |
2.1 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.3 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.1 |
0.2 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.1 |
0.6 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.1 |
1.8 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.1 |
1.5 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.1 |
1.0 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.1 |
2.6 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 |
1.5 |
GO:0033866 |
coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.1 |
3.0 |
GO:2000045 |
regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
| 0.1 |
0.3 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
1.2 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.5 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.7 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
0.6 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.1 |
1.7 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.1 |
0.5 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
0.6 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 |
0.6 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.3 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.1 |
1.6 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.1 |
0.6 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.6 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 |
0.3 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.1 |
1.5 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.1 |
1.9 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.1 |
0.9 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
2.7 |
GO:0031016 |
pancreas development(GO:0031016) |
| 0.1 |
0.5 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.1 |
1.0 |
GO:0045930 |
negative regulation of mitotic cell cycle(GO:0045930) |
| 0.1 |
0.9 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.1 |
0.3 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.1 |
5.4 |
GO:0042633 |
molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.1 |
0.6 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.1 |
0.3 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.1 |
1.3 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.6 |
GO:1902285 |
semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.1 |
2.2 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.1 |
1.1 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.1 |
1.6 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 0.1 |
0.3 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 |
1.6 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.1 |
1.5 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.1 |
0.5 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.1 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.1 |
0.3 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.7 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.1 |
1.2 |
GO:0043627 |
response to estrogen(GO:0043627) |
| 0.1 |
1.3 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.1 |
1.1 |
GO:0051881 |
regulation of mitochondrial membrane potential(GO:0051881) |
| 0.1 |
0.6 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.1 |
1.1 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.1 |
0.6 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
1.4 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.1 |
0.2 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.1 |
0.2 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.1 |
1.5 |
GO:0051193 |
regulation of cofactor metabolic process(GO:0051193) |
| 0.1 |
0.2 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.1 |
1.0 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.9 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.1 |
1.5 |
GO:0042267 |
natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.1 |
0.5 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 |
0.9 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
0.7 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.1 |
2.4 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.1 |
0.7 |
GO:0055010 |
ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.1 |
0.5 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 |
0.3 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.1 |
0.5 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.1 |
0.7 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
3.0 |
GO:0051099 |
positive regulation of binding(GO:0051099) |
| 0.1 |
0.9 |
GO:0010389 |
regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.1 |
0.7 |
GO:0044818 |
mitotic G2/M transition checkpoint(GO:0044818) |
| 0.1 |
2.0 |
GO:0045931 |
positive regulation of mitotic cell cycle(GO:0045931) |
| 0.1 |
1.3 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.1 |
1.5 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.1 |
1.4 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.1 |
0.7 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.1 |
2.3 |
GO:1903038 |
negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
| 0.1 |
0.2 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
1.5 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.1 |
0.3 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.1 |
0.3 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.1 |
11.3 |
GO:0032259 |
methylation(GO:0032259) |
| 0.1 |
0.3 |
GO:0044774 |
mitotic DNA integrity checkpoint(GO:0044774) |
| 0.1 |
1.9 |
GO:0042476 |
odontogenesis(GO:0042476) |
| 0.1 |
0.5 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
3.0 |
GO:0007050 |
cell cycle arrest(GO:0007050) |
| 0.1 |
0.5 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.1 |
0.2 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.1 |
0.1 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.1 |
0.9 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 |
0.1 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.1 |
0.2 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.1 |
0.2 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.1 |
1.4 |
GO:0051897 |
positive regulation of protein kinase B signaling(GO:0051897) |
| 0.1 |
0.5 |
GO:0061371 |
determination of heart left/right asymmetry(GO:0061371) |
| 0.1 |
0.2 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
0.5 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
1.0 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
3.0 |
GO:0007179 |
transforming growth factor beta receptor signaling pathway(GO:0007179) |
| 0.1 |
0.5 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 |
0.3 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
0.3 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.1 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
1.6 |
GO:0048008 |
platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.0 |
0.9 |
GO:0001667 |
ameboidal-type cell migration(GO:0001667) |
| 0.0 |
0.1 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.0 |
1.5 |
GO:0051291 |
protein heterooligomerization(GO:0051291) |
| 0.0 |
2.7 |
GO:0031109 |
microtubule polymerization or depolymerization(GO:0031109) |
| 0.0 |
0.4 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.0 |
0.1 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
1.3 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.0 |
1.1 |
GO:0061515 |
myeloid cell development(GO:0061515) |
| 0.0 |
0.4 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.0 |
0.8 |
GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.0 |
0.7 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.0 |
0.5 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.5 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.0 |
1.0 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 |
0.1 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.0 |
0.2 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.2 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.4 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.0 |
0.4 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.0 |
1.0 |
GO:0045333 |
cellular respiration(GO:0045333) |
| 0.0 |
0.1 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.0 |
0.3 |
GO:0071560 |
cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 0.0 |
0.2 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.1 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.2 |
GO:0045807 |
positive regulation of endocytosis(GO:0045807) |
| 0.0 |
0.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.4 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.0 |
0.4 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
0.3 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) protein targeting to ER(GO:0045047) |
| 0.0 |
0.6 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.1 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.4 |
GO:0051180 |
vitamin transport(GO:0051180) |
| 0.0 |
0.0 |
GO:0010889 |
regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) sequestering of triglyceride(GO:0030730) |
| 0.0 |
0.2 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.1 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.0 |
0.2 |
GO:0051592 |
response to calcium ion(GO:0051592) |
| 0.0 |
0.3 |
GO:0006633 |
fatty acid biosynthetic process(GO:0006633) |
| 0.0 |
0.0 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.5 |
GO:0007338 |
single fertilization(GO:0007338) |
| 0.0 |
0.1 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.5 |
GO:0032648 |
regulation of interferon-beta production(GO:0032648) |
| 0.0 |
0.2 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.0 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.0 |
0.1 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
